A Popular “Brain Supplement” Ingredient Was Just Linked to Shorter Lifespan in Men

  • September 10, 2026
  • 0 Comments

Tyrosine is a familiar name on nootropic and “brain fog” supplement labels, marketed for focus, stress resilience, and mental performance. A large new UK Biobank analysis found something considerably less flattering: higher circulating tyrosine levels are associated with a measurably shorter lifespan — specifically in men. What the Study Actually Did Published in the journal […]

A New Obesity Pill Targets Muscle Instead of Appetite — No GLP-1 Involved

  • September 10, 2026
  • 0 Comments

Nearly every headline about obesity medication right now is about a GLP-1 drug — a new dose, a new oral version, a new triple-agonist. A genuinely different approach is quietly moving through early human trials, and it skips the appetite-suppression mechanism entirely. Instead of acting on the gut-brain signaling GLP-1 drugs use, this oral compound […]

The FDA Just Warned Five Online Peptide Vendors — Here’s What It Means

  • September 9, 2026
  • 0 Comments

If you have seen “research peptides” — semaglutide, tirzepatide, or lesser-known compounds sold as injectable vials, marketed as being for laboratory research only — advertised online, a new round of FDA enforcement is worth knowing about, because it directly addresses the labeling workaround these sellers have relied on. What Actually Happened In letters dated August […]